GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (TSXV:APC.H) » Definitions » Total Assets

Advanced Proteome Therapeutics (TSXV:APC.H) Total Assets : C$0.09 Mil (As of Apr. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Advanced Proteome Therapeutics Total Assets?

Advanced Proteome Therapeutics's Total Assets for the quarter that ended in Apr. 2023 was C$0.09 Mil.

Total Assets is connected with ROA %. Advanced Proteome Therapeutics's annualized ROA % for the quarter that ended in Apr. 2023 was -3,048.57%. Total Assets is also linked to Revenue through Asset Turnover. Advanced Proteome Therapeutics's Asset Turnover for the quarter that ended in Apr. 2023 was 0.00.


Advanced Proteome Therapeutics Total Assets Historical Data

The historical data trend for Advanced Proteome Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Total Assets Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.22 0.03 1.13 0.82

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.08 0.82 0.55 0.44 0.09

Advanced Proteome Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Advanced Proteome Therapeutics's Total Assets for the fiscal year that ended in Jul. 2022 is calculated as

Total Assets=Total Equity (A: Jul. 2022 )+Total Liabilities (A: Jul. 2022 )
=-1.101+1.924
=0.82

Advanced Proteome Therapeutics's Total Assets for the quarter that ended in Apr. 2023 is calculated as

Total Assets=Total Equity (Q: Apr. 2023 )+Total Liabilities (Q: Apr. 2023 )
=-0.03+0.113
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Proteome Therapeutics  (TSXV:APC.H) Total Assets Explanation

Total Assets is connected with ROA %.

Advanced Proteome Therapeutics's annualized ROA % for the quarter that ended in Apr. 2023 is

ROA %=Net Income (Q: Apr. 2023 )/( (Total Assets (Q: Jan. 2023 )+Total Assets (Q: Apr. 2023 ))/ count )
=-7.972/( (0.438+0.085)/ 2 )
=-7.972/0.2615
=-3,048.57 %

Note: The Net Income data used here is four times the quarterly (Apr. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Advanced Proteome Therapeutics's Asset Turnover for the quarter that ended in Apr. 2023 is

Asset Turnover
=Revenue (Q: Apr. 2023 )/( (Total Assets (Q: Jan. 2023 )+Total Assets (Q: Apr. 2023 ))/ count )
=0/( (0.438+0.085)/ 2 )
=0/0.2615
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Advanced Proteome Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Proteome Therapeutics (TSXV:APC.H) Business Description

Traded in Other Exchanges
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (TSXV:APC.H) Headlines

No Headlines